Dyno Therapeutics
Biotechnology Research
Watertown, Massachusetts 16,274 followers
We build AI-powered gene therapies.
Meet Our Leadership Team
Our Leaders are empowering diverse teams of high-potential problem solvers to transform patient lives with cutting edge science.
Who We Are
Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV). Our team includes world-class molecular and synthetic biologists, protein engineers and gene therapy scientists working alongside software engineers, data scientists, and AI and machine learning experts. We believe the future of gene therapy is within reach.
What We're Building
Gene vectors are the key for enabling gene therapies to reach a wider range of diseases and patients. The efficacy of gene therapies, however, is currently limited by the roster of naturally occurring vectors, which are not optimized for disease treatment. To solve this problem, Dyno is building its portfolio of proprietary AAV vectors, and working with licensing partners to build targeted AAV vectors enabling treatments in a wide range of disease areas and indications.
Capsid Map Platform Dyno's Capsid ProductsWhy Join Dyno?
At Dyno, our culture empowers diverse teams of high-potential problem solvers to transform patient lives with innovative science. We are solving complex engineering and scientific challenges and creating a cutting edge computational platform driven by machine learning. Our team promotes respect, openness, and support while creating meaningful results through bold, mindful processes.
Meet Your Future Colleagues